News and Events
Celebrating CCR Careers: Alan Rein, Ph.D.
Alan Rein, Ph.D., is a known expert in the field of viral assembly, particularly in retroviruses like the human immunodeficiency virus (HIV). After an extensive career studying molecular mechanisms of retroviral replication and pathogenesis, he has announced his retirement.
Read More
Clinical trial researching combination immunotherapy for colorectal cancer
A trial led by Jason M. Redman, M.D., Assistant Research Physician in the Center for Immuno-Oncology, is studying combination immunotherapy for colorectal cancer.
Read More
Celebrating CCR Careers: David D. Roberts, Ph.D.
David D. Roberts, Ph.D., a biochemist who identified a new pathway that controls cell responses to stress and developed approaches to improve cancer therapy by shutting it down, announces his retirement from the NCI.
Read More
Clinical trial researching drug therapy for neuroendocrine neoplasms
A trial led by Jaydira Del Rivero, M.D., Associate Research Physician in the Developmental Therapeutics Branch, is studying a new drug for neuroendocrine neoplasms, a group of rare cancers.
Read More
Master regulators flip the switch on neuroblastoma’s developmental state
Waves of regulatory changes can transform self-renewing neuroblastoma cells into neurons.
Read More
Benign nail condition linked to rare syndrome that greatly increases cancer risk
Researchers from CCR and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) discovered the presence of a benign nail abnormality may lead to the diagnosis of a rare inherited disorder that increases the risk of developing cancerous tumors. The study suggests conducting nail evaluation of affected patients and at-risk family members.
Read More
Aligned Blog: Building Community: Celebrating AANHPI Heritage Month
The COVID-19 pandemic highlighted an alarming trend in anti-Asian hate across the United States. To celebrate Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Heritage Month, Sonia A. Garcia, Ph.D., Scientific Diversity Program Manager in CCR's Office of Equity & Inclusion (OEI), highlights an NIH initiative created out of such adversity and shares the OEI's upcoming seminar series on advancing AANHPI folks into leadership positions.
Read More
New AI tool classifies brain tumors using images of tumor slides
A new artificial intelligence model has been found to be highly effective at identifying brain tumor subtypes — with 95% accuracy — simply by analyzing a standard pathology image of the tumor tissue.
Read More
New research identifies a protein essential to maintaining chromosomal stability
Researchers discovered how overproduction of a protein called CENP-A can lead to chromosomal abnormalities, which are found in many types of cancer.
Read More
New database of sarcoma cell line data will drive rare cancer research
CCR researchers have developed the largest publicly accessible sarcoma cell line database called Sarcoma CellMinerCDB. The tool merges previously available and new sarcoma cell line data that can be used to identify new therapeutic targets for these cancers.
Read More
Clinical trial researching combination therapy for solid tumors
A trial led by Steven A. Rosenberg, M.D., Ph.D., Chief of the Surgery Branch, is researching white blood cell gene therapy and vaccine therapy for certain metastatic cancers.
Read More